Xianglong Pan,Shengzhe Zhou,Zhihua Li et al.
Xianglong Pan et al.
Background: Anatomical sublobar resection (ASR) is non-inferior to lobectomy for peripheral small-sized lung cancer. However, for nodules located in complex locations, ASR is usually challenging. This study aimed to compa...
Immune-Mediated Multilineage Cytopenias in Thymoma: A Retrospective Case Series [0.03%]
前胸膜肿瘤伴发的免疫介导多系血液细胞减少症：回顾性病例系列研究
Naibo Hu,Yansong Wei,Weinan Lin et al.
Naibo Hu et al.
Background: Thymoma is associated with diverse immune abnormalities, yet immune-mediated multilineage cytopenias are exceedingly rare and poorly defined. Their clinical features, immunologic patterns, and treatment outcom...
Case Reports
Thoracic cancer. 2026 Jan;17(2):e70248. DOI:10.1111/1759-7714.70248 2026
Trends and Survival Outcomes of Lung Cancer Surgery in South Korea, 2015-2019 [0.03%]
2015-2019年韩国肺癌手术趋势及生存结局
Chanwoo Kim,Kyoung Eun Yeob,Hee-Sung Kim et al.
Chanwoo Kim et al.
Purpose: Lung cancer remains the leading cause of cancer-related deaths in South Korea, yet a comprehensive evaluation that encompasses evolving patterns of operative choice and their impact on survival outcomes by pathol...
Risk Factors of Hematological Toxicity of Mesothelioma Treatment-A Territory-Wide Retrospective Study [0.03%]
一项全港范围回顾性研究：间皮瘤治疗的血液学毒副反应的影响因素分析
Wang Chun Kwok,Desmond Yat Hin Yap,Isaac Sze Him Leung et al.
Wang Chun Kwok et al.
Background: While chemotherapy remains the treatment of choice for mesothelioma, it carries significant toxicities, especially hematological toxicity. Met...
Study of Imaging Analysis for Distinguishing Alveolar Collapse From Invasive Lesions in Early-Stage Lung Adenocarcinoma [0.03%]
鉴别早期肺腺癌终末支气管-alveolus单元病变与肺组织结构破坏的影像学分析研究
Shinji Kaneda,Atsushi Ito,Daisuke Ito et al.
Shinji Kaneda et al.
Background: Non-invasive lung adenocarcinoma may occasionally contain solid benign components, presenting challenges for making an accurate diagnosis using CT (computed tomography). Therefore, we investigated whether a th...
Evolving Patterns of Care, Outcomes and Ongoing Challenges for Early-Stage Non-Small Cell Lung Cancer in the Immunotherapy Era: A Queensland Population-Based Study [0.03%]
免疫治疗时代的早期非小细胞肺癌治疗模式、结局及持续挑战：一项基于昆士兰人口的研究
Bryan A Chan,Danny R Youlden,Andrew Pattison et al.
Bryan A Chan et al.
Introduction: This retrospective study describes contemporary patterns of care and outcomes for early-stage non-small cell lung cancer (NSCLC) in Queensland, Australia, with a focus on immunotherapy. ...
Microwave Ablation Combined With Chemotherapy Versus Chemotherapy Alone in Patients With Advanced Non-Small Cell Lung Cancer-Systematic Review and Meta-Analysis [0.03%]
微波消融联合化疗与单纯化疗治疗晚期非小细胞肺癌患者的系统评价和 meta 分析
Paul C Onyeji,Amrinder Kaur,Leo Consoli et al.
Paul C Onyeji et al.
Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality worldwide. Although chemotherapy remains a cornerstone in the treatment of advanced NSCLC, local ablative strategies such as microwave ablation (MWA) h...
Meta-Analysis
Thoracic cancer. 2026 Jan;17(1):e70221. DOI:10.1111/1759-7714.70221 2026
Leveraging Genetic Instrumental Variables and Sequencing Analysis to Identify a Prognostic Signature Based on Epithelial Cell Markers in Lung Adenocarcinoma [0.03%]
基于基因遗传学的 instrumental variable 和测序分析寻找肺腺癌上皮细胞标志物预后信号通路
Jiaye Lao,Ziqing Han,Xinjing Lou et al.
Jiaye Lao et al.
Main problem: The treatment and prognosis of lung adenocarcinoma (LUAD) remain challenging. The study aimed to identify prognostic genes and construct a prognostic model for LUAD. ...
Multiple Primary Lung Cancer With Driver Gene Mutations: Is Targeted Therapy Always the Optimal Choice?-A Case Report [0.03%]
驱动基因突变的多原发肺癌是否都适合靶向治疗？——一例报告
Zi-Rui Ren,Lv Wu,Chang Lu et al.
Zi-Rui Ren et al.
Targeted therapy is the standard treatment for driver-mutated lung cancer, but its efficacy in multiple primary lung cancers (MPLCs) remains limited due to significant inter-lesional molecular heterogeneity. We present a case of synchronous...
Case Reports
Thoracic cancer. 2026 Jan;17(1):e70215. DOI:10.1111/1759-7714.70215 2026
Non-Small Cell Lung Cancer Patients With Tumors ≤ 2 Cm Are Suitable for Wedge Resection or Segmentectomy: A Real-World Study [0.03%]
肿瘤小于或等于2厘米的非小细胞肺癌患者适合进行楔形切除或节段切除：一项真实世界的研究
Yuetian Pan,Xincheng Li,Ying Ji et al.
Yuetian Pan et al.
Background: The role of wedge resection in the treatment of non-small cell lung cancer (NSCLC) with solid components ≤ 2 cm remains controversial. This study compared the efficacy of wedge resection with that of segmente...